Juvenile dermatomyositis at diagnosis: Clinical characteristics of 79 children

Journal of Rheumatology

Volumn 25, Issue 6, 1998, Pages 1198-1204

  Pachman, Lauren M ^a,b   Hayford, Jennifer R ^a   Chung, Ahn ^a,b   Daugherty, Claire A ^a,b   Pallansch, Mark A ^a,c   Fink, Chester W ^a,d   Gewanter, Harry L ^a,e   Jerath, Rita ^a,f   Lang, Bianca A ^a,g   Sinacore, James ^a,h   Szer, Ilona S ^a,i   Dyer, Alan R ^a,b   Hochberg, Marc C ^a,j  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e Redmont Pediatric Associates   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g DALHOUSIE UNIVERSITY   (Canada)

^h UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁱ RADY CHILDREN'S HOSPITAL   (United States)

^j UNIVERSITY OF MARYLAND   (United States)

more..

Author keywords

Access to medical care; Clinical laboratory; Epidemiology; Juvenile dermatomyositis

Indexed keywords

ADOLESCENT; ARTICLE; CALCINOSIS; CHILD; DEMOGRAPHY; DERMATOMYOSITIS; ELECTROMYOGRAM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; PRIORITY JOURNAL; SOCIOECONOMICS;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMOGRAPHY; DERMATOMYOSITIS; ETHNIC GROUPS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; MALE; MUSCLE, SKELETAL; SEASONS; SOCIAL CLASS; TIME FACTORS; UNITED STATES;

EID: 0031826344     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hanissian AS, Masi AT, Pitner SE, et al. Polymositis and dermatomyositis in children: an epidemiological and clinical comparative analysis. J Rheumatol 1982;9:390-4.
2. Banker BQ, Victor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine 1966;45:261-89.
3. Bohan A, Peter JB, Bowman RL. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977;56:255-86.
4. Sullivan DB, Cassidy JT, Petty RE. Dermatomyositis in the pediatric patient. Arthritis Rheum 1977;20:327-33.
5. Cassidy JT, Petty RE. Juvenile dermatomyositis. In: Cassidy JT, Petty RE, editors. Textbook of pediatric rheumatology. Philadelphia: Saunders, 1995:323-64.
6. Bitnum C, Daeschner CW, Travis LB, et al. Dermatomyositis. J Pediatr 1964;64:101-31.
7. Pachman LM, Cooke N. Juvenile dermatomyositis: a clinical and immunologic study. J Pediatr 1980;96:226-34.
8. Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM. Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 1986;29:1365-70.
9. Pachman LM, Hayford JR. Hochberg MC, et al. Seasonal onset in juvenile dermatomyositis: an epidemiological study [abstract]. Arthritis Rheum 1992;35 Suppl:S88.
10. Leff RL, Burgess SH, Miller FW, et al. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum 1991;34:1391-6.
11. Nam CB, Power MG. The socioeconomic approach to status measurement. Houston: Cap and Gown Press, 1983.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis [parts 1 and 2]. N Engl J Med 1975;292:344-7;403-7.
13. Hanson V. Dermatomyositis, scleroderma and polyarteritis nodosa. Clin Rheum Dis 1976;2:445-65.
14. Benbassat J, Geffel D, Zlotnick A. Epidemiology of polymyositis-dermatomyositis in Israel. Isr J Med Sci 1980;16:197-200.
15. Friedman JM, Pachman LM, Maryjowski ML, et al. Immunogenetic studies of juvenile dermatomysitis: HLA antigens in patients and their families. Tissue Antigens 1983;21:45-9.
16. Symmons DPM, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995;43:732-6.
17. Hernandez RJ, Sullivan DB, Chenevert TL. MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. AJR 1993;161:359-66.
18. Hernandez RJ, Keim DR, Sullivan DB, Chenevert TL, Martel W. Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis. J Pediatr 1990;116:546-50.
19. Pitt AM, Fleckenstein JL, Greenlee RG Jr, Burns DK, Bryan WW, Haller R. MRI-guided biopsy in inflammatory myopathy: initial results. Magn Reson Imaging 1993;11:1093-9.
20. Pachman LM, Crawford S, Morello F, et al. MRI directed muscle biopsy for assessment of juvenile dermatomyositis response to therapy: comparison of initial and follow-up biopsies using a histological rating scale evaluating disease severity/chronicity [abstract]. Arthritis Rheum 1996;39 Suppl:S191.
21. O'Gorman MRG, Corrochano V, Roleck J, Donovan M, Pachman LM. Flow cytometric analysis of the lymphocyte subsets in peripheral blood of children with untreated active juvenile dermatomyositis. Clin Diag Lab Immunol 1995;2:205-8.
22. Eisenstein DM, O'Gorman MRG, Pachman LM. Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomyositis. J Rheumatol 1997;24:1830-2.
23. DeBenedetti F, DeAmici M, Aramini L, Ruperto N, Martini A. Correlations of serum neopterin concentrations with disease activity in juvenile dermatomyositis. Arch Dis Child 1993;69:232-5.
24. Guzman J, Petty RE, Malleson PN. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumatol 1994;21:739-43.
25. Pachman LM. Imperfect indications of disease activity in juvenile dermatomyositis. J Rheumatol 1995;2:193-7.
26. Pachman LM. An update on juvenile dermatomyositis. Curr Opin Rheumatol 1995;7:437-41.
27. Rider LG, Okada S, Sherry DD, et al. Epidemiologic features and environmental exposure associated with illness onset in juvenile idiopathic inflammatory myopathy [abstract]. Arthritis Rheum 1995;38 Suppl:S362.
28. Hiketa T, Ohashi M. Juvenile dermatomyositis - statistical observation of 105 patients with dermatomyositis. Jap J Dermatol 1991;101:825-30.
29. Hochberg MC. Epidemiology of polymyositis/dermatomyositis. Mt Sinai J Med 1988;55:447-52.
30. Hochberg MC, Lopez-Acuna D, Gittlesohn AM. Mortality from polymyositis and dermatomyositis in the United States, 1968-1978. Arthritis Rheum 1983;26:1465-71.
31. Pachman LM, Hayford JR, Hochberg M, et al. New onset juvenile dermatomyositis: comparisons with children with JRA and healthy children. Arthritis Rheum 1997;40:1526-33.
32. Bridges BF. The rashes of dermatomyositis in a black patient. Am J Med 1991;91:661-2.
33. Medsger TA Jr, Dawson WN, Masi AT. The epidemiology of polymyositis. Am J Med 1970;48:715-23.
34. Koch MJ, Brody JA, Gillespie MM. Childhood polymyositis: a case-controlled study. Am J Epidemiol 1976;104:627-31.
35. Rosenberg AM. Geographical clustering of childhood dermatomyositis in Saskatchewan [abstract]. Arthritis Rheum 1994;37 Suppl:S402.
36. Manta P, Kalfakis N, Vassilopoulos D. Evidence for seasonal variation in polymyositis. Neuroepidemiology 1989;8:262-6.